ReShape Lifesciences Inc.

NASDAQ:RSLS   3:59:51 PM EDT
0.56
-0.01 (-1.05%)
Earnings Announcements

ReShape Lifesciences Reports Q1 Financial Results And Provides Corporate Update

Published: 05/23/2022 12:51 GMT
ReShape Lifesciences Inc. (RSLS) - Reshape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Revenue $2.4 Million.
Qtrly Loss per Share $0.44.
Cash and Cash Equivalents Were $15.5 Million As of March 31, 2022.
Revenue is expected to be $3.83 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $5.3 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.